Eco R1 Capital, LLC Solid Biosciences Inc. Transaction History

Eco R1 Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.43 - $1.24 $1.1 Million - $3.18 Million	-2,565,102 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.74 - $1.79 $4.91 Million - $11.9 Million	-6,637,600 Reduced 72.13%	2,565,102 $3.08 Million
Q1 2021 May 17, 2021	BUY	$5.37 - $10.72 $6.58 Million - $13.1 Million	1,225,000 Added 15.36%	9,202,702 $50.9 Million
Q4 2020 Feb 16, 2021	BUY	$3.08 - $7.79 $24.6 Million - $62.1 Million	7,977,702 New	7,977,702 $60.5 Million
Q4 2019 Feb 14, 2020	SELL	$2.82 - $12.9 $9.43 Million - $43.1 Million	-3,342,691 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.33 - $11.64 $10.9 Million - $29.3 Million	2,515,691 Added 304.19%	3,342,691 $34.6 Million
Q2 2019 Aug 14, 2019	BUY	$4.6 - $10.13 $3.8 Million - $8.38 Million	827,000 New	827,000 $4.76 Million
Q1 2019 May 15, 2019	SELL	$7.19 - $32.37 $6.24 Million - $28.1 Million	-867,246 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$21.32 - $46.34 $18.5 Million - $40.2 Million	867,246 New	867,246 $23.2 Million

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $29.8M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.